EMA recommends approval of etanercept biosimilar

Posted 27/11/2015

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) announced on 19 November 2015 that it had recommended granting of...

Amgen submits biosimilar adalimumab application... Biosimilars/News | Posted 27/11/2015
Prescribing and dispensing generics in Japan Generics/Research | Posted 27/11/2015
AE reporting for biologicals Biosimilars/Research | Posted 27/11/2015
Positive phase III results for etanercept biosi... Biosimilars/Research | Posted 27/11/2015
Proposed rebates will hit patients, not drug co... Generics/General | Posted 27/11/2015
Biosimilar naming in the US, the debate continues Biosimilars/General | Posted 20/11/2015
Safety monitoring of drug interchangeability Generics/Research | Posted 20/11/2015
Biosimilar naming conventions around the world Biosimilars/Research | Posted 20/11/2015
US politicians form Affordable Drug Pricing Tas... Generics/General | Posted 20/11/2015
Positive phase III results for Samsung Bioepis... Biosimilars/Research | Posted 20/11/2015
Celltrion submits rituximab biosimilar applicat... Biosimilars/News | Posted 20/11/2015
Mylan will not be acquiring Perrigo Pharma News | Posted 20/11/2015
World Generic Medicines Congress Europe 2016 Conferences | Posted 20/11/2015
Biologicals patent expiries Biosimilars/General | Posted 13/11/2015
Biosimilars and interchangeability Biosimilars/Research | Posted 13/11/2015
FDA evaluation of residual solvents in generics Generics/Research | Posted 13/11/2015
Economic considerations for rheumatoid arthriti... Biosimilars/Research | Posted 13/11/2015
Pfizer cuts some biosimilars after Hospira deal Pharma News | Posted 13/11/2015
Tentative FDA approval for chemotherapy generic Generics/News | Posted 13/11/2015
Formycon starts phase III trial for ranibizumab... Biosimilars/News | Posted 13/11/2015
Prescribing generics for chronic musculoskeleta... Generics/Research | Posted 06/11/2015
Non-originator low molecular weight heparins: g... Biosimilars/Research | Posted 06/11/2015
Senator calls for FTC to investigate drugmakers... Policies & Legislation | Posted 06/11/2015
Positive phase I results for adalimumab biosimilar Biosimilars/Research | Posted 06/11/2015
FDA making progress with ANDA backlog Generics/General | Posted 06/11/2015
Sandoz launches authorized fluvastatin generic... Generics/News | Posted 06/11/2015
Biosimilar naming and AE reporting Biosimilars/Research | Posted 30/10/2015
FDA evaluation of impurities in generics Generics/Research | Posted 30/10/2015
Biosimilars of ranibizumab Biosimilars/General | Posted 30/10/2015
Boehringer Ingelheim stops biosimilar rituximab... Biosimilars/News | Posted 30/10/2015
Rituximab biosimilar claimed similar pharmacoki... Biosimilars/Research | Posted 30/10/2015
Teva launches enlarged prostate generic in the US Generics/News | Posted 30/10/2015
Biosimilars use in Italy increasing Biosimilars/Research | Posted 23/10/2015
Call for compulsory license for biosimilar tras... Biosimilars/General | Posted 23/10/2015
FDA evaluation of excipients in generics Generics/Research | Posted 23/10/2015
Biosimilars substitution bill becomes law in Ca... Policies & Legislation | Posted 23/10/2015
Candidate infliximab biosimilar SB2 equivalent... Biosimilars/Research | Posted 23/10/2015
Brand-name drugmakers gain extra days of patent... Generics/General | Posted 23/10/2015
Insulin glargine biosimilar in US delayed until... Biosimilars/News | Posted 23/10/2015
ADHD generic receives US FDA approval Generics/News | Posted 23/10/2015
Australia’s DoH seeks feedback on biosimilars a... Biosimilars/General | Posted 16/10/2015
Pharmacovigilance compliance for biocomparables... Biosimilars/Research | Posted 16/10/2015

Generics News Research General


Biosimilars News Research General